Research and Markets: Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mxmhl3/avastin) has announced the addition of the "Avastin (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022" report to their offering.

The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, and neuropathy - is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline.

The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.

Avastin (bevacizumab) is a recombinant humanized IgG1 mAb that specifically binds to VEGF-A, thereby preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells. Through VEGF-A inhibition, Avastin inhibits angiogenesis, and is indicated for the adjunctive treatment of metastatic colorectal cancer as well as for other types of cancer.

Scope

- Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.

- Detailed information on Avastin including product description, safety and efficacy profiles as well as a SWOT analysis.

- Sales forecast for Avastin for the top seven countries from 2012 to 2022.

- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Disease Overview

Disease Management

Competitive Assessment

Avastin (bevacizumab)

Appendix

List of Tables

List of Figures

For more information visit http://www.researchandmarkets.com/research/mxmhl3/avastin

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular